RT Journal Article
SR Electronic
T1 Post-traumatic Stress Risk among COVID-19 Survivors in Colombia
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.12.02.21267210
DO 10.1101/2021.12.02.21267210
A1 Campo-Arias, Adalberto
A1 Pedrozo-Pupo, John Carlos
A1 Herazo, Edwin
YR 2021
UL http://medrxiv.org/content/early/2021/12/05/2021.12.02.21267210.abstract
AB The study’s objective was to establish the prevalence and variables associated with post-traumatic stress disorder risk (PTSD-R) in a sample of COVID-19 survivors in Santa Marta, Colombia. A cross-sectional study was designed with a non-probabilistic sample of adult COVID-19 survivors. Participants were demographically characterized and completed scales for depression risk, insomnia risk, and PTSD-R. Three hundred and thirty COVID-19 survivors between 18 and 89 years participated; 61.52% were women. The frequency of depression risk was 49.70%; insomnia risk, 60.61%; and PTSD-R, 13.33%. Depression risk (OR = 41.43, 95% CI 5.54 – 311.63), insomnia risk (OR = 5.25, 95% CI 1.77 – 18.71), low income (OR = 3.46, 95% CI 1.38 – 8.67) and being married or free union (OR = 2.65, 95% CI 1.13 – 6.22) were associated with PTSD-R. In conclusion, two out of every fifteen COVID-19 survivors are in PTSD-R. Depression and insomnia risk are strongly associated with PTSD-R in COVID-19 survivors.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe Universidad del Magdalena, Santa Marta, Colombia, funded the project.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:THe Research Ethics Committee approved the study of the Universidad del Magdalena, Santa Marta, Colombia (Approval Certificate 002 of March 26, 2020).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available from the corresponding author upon reasonable request.